Peptides DB
Research-centric peptide and protocol reference hub
Study 22 of 24Teriparatide (PTH 1-34) literatureIn vivo (Athens, Greece) · Observational2026

Combined Teriparatide and Exercise Effects on Diabetic Skeletal Muscle Ultrastructure.

The combination of teriparatide and exercise may induce structural changes in skeletal muscle and mitochondria in diabetic mice, but the clinical relevance of these findings remains uncertain.

Read at In vivo (Athens, Greece)Add to compare

Where it sits

this study against the rest of the teriparatide (pth 1-34) corpus
1
Preclinical
18
Observational · this one
0
Open-label
3
Randomised
2
Reviews

Summary and findings

This study measured the effects of combined teriparatide (TPTD) administration and exercise on skeletal muscle and mitochondrial ultrastructure in diabetic Akita mice. TPTD was administered at a dose of 80 μg/kg subcutaneously three times weekly for six weeks, alongside treadmill exercise five days a week. The findings suggest structural changes in skeletal muscle and mitochondria under diabetic conditions.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as In vivo (Athens, Greece) supplied them

<h4>Background/aim</h4>The effects of combined teriparatide (TPTD) administration and exercise therapy on diabetic skeletal muscle remain unclear. This study investigated the effects of combined TPTD and treadmill exercise on skeletal muscle and mitochondrial ultrastructure in Akita mice, a model of type 1 diabetes.<h4>Materials and methods</h4>Male C57BL/6J-Ins2<Akita>/J mice were randomly assigned to four groups: control, exercise therapy (EX), TPTD administration, and combined exercise plus TPTD (EXTP) (n=6 each). TPTD (80 μg/kg) was administered subcutaneously three times weekly for six weeks, and treadmill exercise was performed five days/week. Body weight, fasting blood glucose, grip strength, wet muscle weight, muscle fibre cross-sectional area (CSA), mitochondrial and sarcomere ultrastructure, and gene expression were evaluated.<h4>Results</h4>Baseline fasting blood glucose levels were higher in the EXTP group than in the EX and TPTD groups. The EXTP group showed a greater reduction in fasting blood glucose than the other groups and higher wet muscle weight normalised to tibial length than the control group. A-band length and A-band length normalised to tibial length were also higher in the EXTP group. Electron microscopy showed larger subsarcolemmal and intermyofibrillar mitochondrial CSA in the EXTP group. Body weight-normalised grip strength, muscle fibre CSA, myofibril CSA, mitochondrial number, aspect ratio, roundness, and most gene expression levels did not differ among groups.<h4>Conclusion</h4>Combined TPTD administration and exercise therapy may induce structural changes in skeletal muscle and mitochondria under diabetic conditions and may contribute to maintenance or remodelling of skeletal muscle ultrastructure and mitochondrial morphology.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Teriparatide (PTH 1-34) corpus

BPhenotypic-Genotypic Discordance in Renal Tubular Acidosis with Hypokalemic Rhabdomyolysis and a TRAPPC2 Variant: A Case Reportbiorxiv-preprint · 2023 · n=1 · Serum potassium was 1.7 mmol/L during an acute episode.HumanDPerioperative Anabolic Osteoporosis Pharmacotherapy Is Associated With Lower Rates of Proximal Junctional Kyphosis After Adult Spinal Deformity Surgery: A Systematic Review and Meta-Analysis.Spine · 2026 · PJK odds reduced with anabolic pharmacotherapy, pooled OR 0.51, 95% CI 0.30 to 0.86, P=0.012, I2=0%, k=5.reviewDParathyroid Hormone for Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis.Oral diseases · 2026 · Odds ratio 5.81.reviewBReal-World Effectiveness of Osteoporosis Treatments on Bone Strength and the Impact of Sequential Anabolic Therapybiorxiv-preprint · 2026 · 39.5% increase in vertebral strength with Romo at 12 months, n=57, 95% CI [34.2, 44.7]HumanABioengineered acellular tissue engineered vessels versus autogenous fistulae for haemodialysis access: a multicentre, randomised, controlled, phase 3 trial.The Lancet. Digital health · 2026 · n=242 · Global relative patency of 1·17 (95% CI 1·04-1·31, p=0·0090).HumanCAscorbic acid mitigates oxidative structural degradation in bovine spermatozoa: a label-free quantitative phase microscopy study.Veterinary and animal science · 2026 · Not reported in abstract.Animal